Genprex (GNPX) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $2.11, -7.86% vs the prior close of $2.29.
- Volume 123.37K shares, 0.5x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
GNPX slides 7.9% to $2.11, a 52-week low, 6 down days in a row. Closed at $2.11, -7.86% vs the prior close of $2.29. Day range $2.10–$2.32, opened at $2.24.
GNPX daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — GNPX slides 7.9% to $2.11, a 52-week low, 6 down days in a row
- Closed at $2.11, -7.86% vs the prior close of $2.29. Day range $2.10–$2.32, opened at $2.24.
- Volume was 123.37K shares, 0.5x its 50-day average of 259.14K — lighter than usual.
- Price is -38.5% vs its 50-day average ($3.43) and -90.7% vs its 200-day average ($22.66).
- 52-week range $2.10–$753.50; today's close sits at 0% of that range, 99.7% below the 52-week high.
- That makes 6 straight losses.
Oct 15, 2026 — GNPX dips 1.7% to $2.29, a 52-week low, 5 down days in a row
- Closed at $2.29, -1.72% vs the prior close of $2.33. Day range $2.21–$2.43, opened at $2.30.
- Volume was 224.80K shares, 0.9x its 50-day average of 256.77K.
- Price is -34.2% vs its 50-day average ($3.48) and -90.0% vs its 200-day average ($22.84).
- 52-week range $2.21–$1,210.00; today's close sits at 0% of that range, 99.8% below the 52-week high.
- That makes 5 straight losses.
Oct 14, 2026 — GNPX slides 7.2% to $2.33, a 52-week low, 4 down days in a row
- Closed at $2.33, -7.17% vs the prior close of $2.51. Day range $2.30–$2.55, opened at $2.50.
- Volume was 281.20K shares, 1.1x its 50-day average of 259.33K.
- Price is -33.8% vs its 50-day average ($3.52) and -89.9% vs its 200-day average ($23.02).
- 52-week range $2.30–$1,210.00; today's close sits at 0% of that range, 99.8% below the 52-week high.
- That makes 4 straight losses.
Oct 13, 2026 — GNPX slides 6.7% to $2.51, a 52-week low, 3 down days in a row
- Closed at $2.51, -6.69% vs the prior close of $2.69. Day range $2.51–$2.69, opened at $2.65.
- Volume was 165.30K shares, 0.5x its 50-day average of 312.38K — lighter than usual.
- Price is -29.6% vs its 50-day average ($3.56) and -89.2% vs its 200-day average ($23.21).
- 52-week range $2.51–$1,210.00; today's close sits at 0% of that range, 99.8% below the 52-week high.
- That makes 3 straight losses.
Oct 12, 2026 — GNPX dips 1.1% to $2.69
- Closed at $2.69, -1.10% vs the prior close of $2.72. Day range $2.57–$2.88, opened at $2.88.
- Volume was 275.50K shares, 0.9x its 50-day average of 307.45K.
- Price is -25.4% vs its 50-day average ($3.61) and -88.5% vs its 200-day average ($23.40).
- 52-week range $2.53–$1,210.00; today's close sits at 0% of that range, 99.8% below the 52-week high.
Oct 9, 2026 — GNPX dips 1.1% to $2.72
- Closed at $2.72, -1.09% vs the prior close of $2.75. Day range $2.64–$2.93, opened at $2.81.
- Volume was 201.30K shares, 0.7x its 50-day average of 304.23K.
- Price is -26.0% vs its 50-day average ($3.67) and -88.5% vs its 200-day average ($23.60).
- 52-week range $2.53–$1,210.00; today's close sits at 0% of that range, 99.8% below the 52-week high.
Oct 8, 2026 — GNPX jumps 5.0% to $2.75
- Closed at $2.75, +4.96% vs the prior close of $2.62. Day range $2.66–$2.81, opened at $2.69.
- Volume was 252.40K shares, 0.8x its 50-day average of 299.61K.
- Price is -26.5% vs its 50-day average ($3.74) and -88.4% vs its 200-day average ($23.80).
- 52-week range $2.53–$1,210.00; today's close sits at 0% of that range, 99.8% below the 52-week high.
Oct 7, 2026 — GNPX rises 0.4% to $2.62
- Closed at $2.62, +0.38% vs the prior close of $2.61. Day range $2.58–$2.78, opened at $2.62.
- Volume was 227.60K shares, 0.8x its 50-day average of 295.29K.
- Price is -31.6% vs its 50-day average ($3.83) and -89.1% vs its 200-day average ($24.02).
- 52-week range $2.53–$1,210.00; today's close sits at 0% of that range, 99.8% below the 52-week high.
Oct 6, 2026 — GNPX slides 4.0% to $2.61
- Closed at $2.61, -4.04% vs the prior close of $2.72. Day range $2.58–$2.75, opened at $2.74.
- Volume was 156.10K shares, 0.5x its 50-day average of 292.41K — lighter than usual.
- Price is -33.7% vs its 50-day average ($3.94) and -89.2% vs its 200-day average ($24.25).
- 52-week range $2.53–$1,210.00; today's close sits at 0% of that range, 99.8% below the 52-week high.
Oct 5, 2026 — GNPX jumps 3.4% to $2.72
- Closed at $2.72, +3.42% vs the prior close of $2.63. Day range $2.61–$2.81, opened at $2.67.
- Volume was 151.70K shares, 0.5x its 50-day average of 289.63K — lighter than usual.
- Price is -32.7% vs its 50-day average ($4.04) and -88.9% vs its 200-day average ($24.49).
- 52-week range $2.53–$1,210.00; today's close sits at 0% of that range, 99.8% below the 52-week high.
Oct 2, 2026 — GNPX rises 2.7% to $2.63
- Closed at $2.63, +2.73% vs the prior close of $2.56. Day range $2.55–$2.75, opened at $2.56.
- Volume was 118.70K shares, 0.4x its 50-day average of 287.65K — lighter than usual.
- Price is -36.5% vs its 50-day average ($4.14) and -89.4% vs its 200-day average ($24.75).
- 52-week range $2.53–$1,210.00; today's close sits at 0% of that range, 99.8% below the 52-week high.
GNPX latest news & SEC filings
Every SEC filing by or about GNPX in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Aug 18, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Aug 14, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$4.45M (prior year -$4.67M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$9.40 (prior year -$185.30) (loss narrowed vs Jun 30, 2025)
Aug 5, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 3.01 — Stock exchange listing notice or transfer of listing.
Aug 3, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Jul 30, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 3.01 — Stock exchange listing notice or transfer of listing.
- Item 8.01 — Reported other events the company considers important.
Jul 14, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 3.03 — Change to shareholder rights.
- Item 5.03 — Amended its charter or bylaws / changed fiscal year.
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
- Item 8.01 — Reported other events the company considers important.
Jun 26, 2026 · Form S-8 — Employee share plan registration
Registration of shares for employee stock plans (S-8)
Jun 22, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Things to know before you trade GNPX
- How much it moves: over the last 20 sessions the average daily move was 4.66% (largest 14.6%). That is a volatile stock.
- Liquidity: about 312.08K shares (≈$658.49K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $2.11 vs a range of $2.10–$753.50 (0% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:22 on Jul 16, 2026, 1:50 on Oct 21, 2025
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 8 sales; latest: Brent M Longnecker sold 8 shares on Apr 14, 2026.
- Latest filings: 8-K Aug 18, 2026; 10-Q Aug 14, 2026; 8-K Aug 5, 2026.
- Share count: 819.71K shares outstanding (Aug 10, 2026), -97.6% vs a year earlier — the company has been reducing its share count.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
GNPX market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 2.24 | 2.32 | 2.10 | 2.11 | 123.37K |
| Oct 15, 2026 | 2.30 | 2.43 | 2.21 | 2.29 | 224.80K |
| Oct 14, 2026 | 2.50 | 2.55 | 2.30 | 2.33 | 281.20K |
| Oct 13, 2026 | 2.65 | 2.69 | 2.51 | 2.51 | 165.30K |
| Oct 12, 2026 | 2.88 | 2.88 | 2.57 | 2.69 | 275.50K |
| Oct 9, 2026 | 2.81 | 2.93 | 2.64 | 2.72 | 201.30K |
| Oct 8, 2026 | 2.69 | 2.81 | 2.66 | 2.75 | 252.40K |
| Oct 7, 2026 | 2.62 | 2.78 | 2.58 | 2.62 | 227.60K |
| Oct 6, 2026 | 2.74 | 2.75 | 2.58 | 2.61 | 156.10K |
| Oct 5, 2026 | 2.67 | 2.81 | 2.61 | 2.72 | 151.70K |
| Oct 2, 2026 | 2.56 | 2.75 | 2.55 | 2.63 | 118.70K |
| Oct 1, 2026 | 2.98 | 2.98 | 2.53 | 2.56 | 141.80K |
| Sep 30, 2026 | 2.82 | 3.06 | 2.76 | 2.92 | 179.30K |
| Sep 29, 2026 | 2.82 | 2.90 | 2.73 | 2.85 | 101.30K |
| Sep 28, 2026 | 3.41 | 3.41 | 2.70 | 2.81 | 568.40K |
| Sep 25, 2026 | 3.54 | 3.55 | 3.26 | 3.29 | 118.80K |
| Sep 24, 2026 | 3.66 | 3.66 | 3.36 | 3.52 | 244.70K |
| Sep 23, 2026 | 3.76 | 4.20 | 3.42 | 3.75 | 2.49M |
| Sep 22, 2026 | 3.54 | 3.60 | 3.47 | 3.54 | 103.80K |
| Sep 21, 2026 | 3.48 | 3.65 | 3.46 | 3.48 | 116.80K |
About Genprex
Genprex (GNPX) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in AUSTIN, TX. State of incorporation: TX. Fiscal year ends December 31. SEC CIK 1595248.
GNPX board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Ryan M. Confer | President, CEO and CFO | Feb 27, 2026 |
| Brent M Longnecker | Director | Apr 15, 2026 |
| Toscano Jose Antonio Moreno | Director | Dec 23, 2025 |
| William R Jr. Wilson | Director | Dec 23, 2025 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Mark Stanley Berger | Chief Medical Officer | Feb 27, 2026 |
| Ryan M. Confer | President, CEO and CFO | Feb 27, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Apr 14, 2026 | Brent M Longnecker | Sale | 8 | $1.23 |
| Apr 14, 2026 | Brent M Longnecker | Sale | 10 | $1.23 |
| Apr 14, 2026 | Brent M Longnecker | Sale | 8 | $1.23 |
| Apr 14, 2026 | Brent M Longnecker | Sale | 10 | $1.23 |
| Apr 14, 2026 | Brent M Longnecker | Sale | 8 | $1.23 |
| Apr 14, 2026 | Brent M Longnecker | Sale | 10 | $1.23 |
| Apr 14, 2026 | Brent M Longnecker | Sale | 8 | $1.23 |
| Apr 14, 2026 | Brent M Longnecker | Sale | 10 | $1.23 |
GNPX financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-16.23M | -17.40 | $-15.31M |
| Dec 31, 2024 | $0 | $-21.11M | -266.89 | $-17.92M |
| Dec 31, 2023 | $0 | $-30.86M | -22.56 | $-24.74M |
| Dec 31, 2022 | $0 | $-23.74M | -19.80 | $-17.62M |
| Dec 31, 2021 | $0 | $-20.66M | -0.44 | $-14.28M |
Latest balance sheet: total assets $17.14M, total liabilities $2.34M, cash $15.15M (as of Jun 30, 2026).
GNPX earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on GNPX
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.